Geode Capital Management LLC Acquires 48,106 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Geode Capital Management LLC boosted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 9.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 546,954 shares of the medical instruments supplier's stock after acquiring an additional 48,106 shares during the period. Geode Capital Management LLC owned approximately 2.23% of ICU Medical worth $99,687,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC increased its position in shares of ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock worth $10,790,000 after acquiring an additional 8,010 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of ICU Medical in the 3rd quarter valued at about $342,000. EP Wealth Advisors LLC bought a new stake in shares of ICU Medical in the third quarter valued at about $247,000. Jane Street Group LLC grew its holdings in shares of ICU Medical by 137.5% during the third quarter. Jane Street Group LLC now owns 28,729 shares of the medical instruments supplier's stock worth $5,235,000 after buying an additional 16,635 shares in the last quarter. Finally, State Street Corp raised its position in ICU Medical by 9.3% in the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after buying an additional 77,506 shares during the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Stock Performance

NASDAQ ICUI traded down $0.87 on Thursday, hitting $153.20. 272,824 shares of the stock were exchanged, compared to its average volume of 270,103. The company has a market capitalization of $3.75 billion, a PE ratio of -33.52 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The business's fifty day moving average is $169.78 and its 200 day moving average is $152.41. ICU Medical, Inc. has a 52 week low of $86.80 and a 52 week high of $196.26.

Insider Transactions at ICU Medical

In related news, Director David C. Greenberg sold 972 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the sale, the director now owns 5,037 shares in the company, valued at approximately $796,400.07. This represents a 16.18 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of ICU Medical stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock worth $6,869,878 in the last ninety days. Insiders own 6.70% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Raymond James increased their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a report on Thursday, September 12th. KeyCorp lifted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research note on Wednesday, November 13th. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $199.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.